Bright Minds Biosciences Inc. (NASDAQ:DRUG – Get Rating) was the target of a significant increase in short interest in October. As of October 15th, there was short interest totalling 478,500 shares, an increase of 34.6% from the September 30th total of 355,600 shares. Based on an average trading volume of 12,270,000 shares, the days-to-cover ratio is presently 0.0 days. Approximately 6.4% of the shares of the stock are short sold.
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in Bright Minds Biosciences stock. Jane Street Group LLC bought a new position in Bright Minds Biosciences Inc. (NASDAQ:DRUG – Get Rating) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 24,701 shares of the company's stock, valued at approximately $37,000. Jane Street Group LLC owned about 0.21% of Bright Minds Biosciences as of its most recent SEC filing. Hedge funds and other institutional investors own 4.03% of the company's stock.
Get Bright Minds Biosciences alerts:Bright Minds Biosciences Trading Up 0.6 %
Shares of Bright Minds Biosciences stock opened at $0.99 on Friday. Bright Minds Biosciences has a one year low of $0.75 and a one year high of $8.95. The business's 50 day moving average price is $1.43 and its 200 day moving average price is $1.14.
Bright Minds Biosciences (NASDAQ:DRUG – Get Rating) last posted its earnings results on Friday, August 12th. The company reported ($0.17) earnings per share for the quarter.Bright Minds Biosciences Company Profile
(Get Rating)
Bright Minds Biosciences Inc, a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry.
Featured Stories
- Get a free copy of the StockNews.com research report on Bright Minds Biosciences (DRUG)
- Will Demand from EV Makers Drive Up Freeport-McMoRan stock?
- Shopify Stock Price Surges as Losses Narrow, Investments Pay Off
- MarketBeat: Week in Review 10/24-10/28
- McDonald's Stock Sizzles, but Will it Hit a New All-Time High?
- Can Comcast Monetize Existing Users for Streaming Success?
Receive News & Ratings for Bright Minds Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bright Minds Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.